Singleron Biotechnologies

📍 Cologne, Germany🗓 Founded 2018👥 89 employees💰 Last funded Jun 2019
Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking high-throughput single cell analyses to clinical research, diagnostics and drug development. 500+ single-cell sequencing experts around the world are working together to translate advanced and proprietary multi-omics single-cell technologies into products that can be easily deployed in any lab and provide improved research results faster than ever before. The company was incorporated in January 2018 and currently has offices and laboratories in China, US, and Germany. Contact: info@singleronbio.com
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
China
1
Frequently asked questions
Who invested in Singleron Biotechnologies?
Singleron Biotechnologies has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Singleron Biotechnologies last raise funding?
The most recent investment in Singleron Biotechnologies recorded on gritt.io was in June 2019.
When was Singleron Biotechnologies founded?
Singleron Biotechnologies was founded in 2018.
What industry is Singleron Biotechnologies in?
Singleron Biotechnologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Singleron Biotechnologies based?
Singleron Biotechnologies is headquartered in Cologne, Germany.